论文部分内容阅读
急性心肌梗死患者血运重建后无复流的防治是冠状动脉再灌注治疗中亟待解决的问题。无复流发生机制复杂。近来众多研究表明,在中医理论指导下运用传统中药,在防治无复流方面往往显示出多层面、多靶点效应,疗效显著,体现了中医药的整体特色优势。并且药理研究也初步阐明中药的部分作用机制,如抑制炎性反应、抗血小板聚集、清除氧自由基等。总之,中药在无复流防治中有着不可替代的重要地位。
Prevention and treatment of no-reflow after revascularization in patients with acute myocardial infarction is a problem to be solved in the treatment of coronary reperfusion. No-reflow mechanism is complicated. Recently, many researches show that using traditional Chinese medicine under the guidance of Chinese medicine theory often shows multi-level and multi-target effects in prevention and treatment of no-reflow, and has significant curative effect. It reflects the overall advantages of traditional Chinese medicine. And pharmacological studies have also initially clarified part of the mechanism of action of traditional Chinese medicine, such as inhibition of inflammatory response, anti-platelet aggregation, scavenging oxygen free radicals. In short, Chinese medicine has an irreplaceable important position in the prevention and treatment of no-reflow disease.